Centricity Research Columbus Dermatology

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials

Phase

• Phase 22 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Celldex Therapeutics1 trial
• Hoffmann-La Roche1 trial

Running trials

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

  NCT06863961· Phase 2· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study of Barzolvolimab in Patients With Atopic Dermatitis

  NCT06727552· Phase 2· Celldex Therapeutics· Source